Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal

Total article views   HTML views PDF downloads Totals
11,090 Dovepress* 9,134+ 1,112 10,246
PubMed Central* 1,956 336 2,292
Totals 11,090 1,448 12,538
*Since 22 August 2018

View citations on PubMed Central and Google Scholar